6827 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
MegaPro Biomedical Co., Ltd. engages in the development of drug ingredients related to nanoparticles and nanocell technology platforms. Its products include iron agent for iron deficiency in chronic kidney diseases, contrast agent for liver and lymph nodes magnetic resonance imaging, and anti-cancer drugs. The company was founded on November 7, 2014 and is headquartered in Hsinchu, Taiwan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
6827 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company